Photys Therapeutics
A proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€273—409m (Dealroom.co estimates Sep 2022.)
Cambridge Massachusetts (HQ)
Authorizing premium user...